The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Vimont, Sophie ^a,b   Boyd, Anders ^b,c   Bleibtreu, Alexandre ^c,d   Bens, Marcelle ^d,e   Goujon, Jean Michel ^f   Garry, Louis ^c,d   Clermont, Olivier ^c,d   Denamur, Erick ^c,d   Arlet, Guillaume ^a,b   Vandewalle, Alain ^d,e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^f POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLADDER; CLONING; COMMENSAL ESCHERICHIA COLI; ESCHERICHIA COLI; GROWTH RATE; IN VITRO STUDY; INFLAMMATION; INOCULATION; INTESTINE; KIDNEY; KIDNEY BLOOD VESSEL; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENICITY; PHYLOGENY; PREVALENCE; URINARY TRACT INFECTION;

ANIMALS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CYTOKINES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; INTESTINES; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C3H; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LURIA; MUS;

EID: 84866999898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046547     Document Type: Article

References (56)

1. Gupta K, Scholes D, Stamm WE, (1999) Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. Jama 281: 736-738.
2. Pitout JD, Nordmann P, Laupland KB, Poirel L, (2005) Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
3. Rodriguez-Bano J, Paterson DL, (2006) A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis 42: 935-937.
4. Paterson DL, Bonomo RA, (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
5. Pitout JD, Laupland KB, (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159-166.
6. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, et al. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14: 195-200.
7. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso M P, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
8. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M, et al. (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51: 286-294.
9. Peirano G, Pitout JD, (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35: 316-321.
10. Owens RC Jr, Johnson JR, Stogsdill P, Yarmus L, Lolans K, et al. (2011) Community Transmission in the United States of a CTX-M-15-Producing Sequence Type ST131 Escherichia coli Strain Resulting in Death. J Clin Microbiol 49: 3406-3408.
11. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-1028.
12. Rogers BA, Sidjabat HE, Paterson DL, (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1-14.
13. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, et al. (2004) Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48: 1249-1255.
14. Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, et al. (2006) Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother 50: 2433-2438.
15. Kaper JB, Nataro JP, Mobley HL, (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
16. Moreno E, Andreu A, Pigrau C, Kuskowski MA, Johnson JR, et al. (2008) Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol 46 (8):: 2529-2534.
17. Myhal ML, Laux DC, Cohen PS, (1982) Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur J Clin Microbiol 1: 186-192.
18. Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, et al. (1997) The complete genome sequence of Escherichia coli K-12. Science 277: 1453-1474.
19. Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, et al. (2009) Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 5: e1000344.
20. Diard M, Garry L, Selva M, Mosser T, Denamur E, et al. (2010) Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization. J Bacteriol 192: 4885-4893.
21. Riley MA, Wertz JE, (2002) Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56: 117-137.
22. Waters VL, Crosa JH, (1991) Colicin V virulence plasmids. Microbiol Rev 55: 437-450.
23. Chang DE, Smalley DJ, Tucker DL, Leatham MP, Norris WE, et al. (2004) Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci U S A 101: 7427-7432.
24. Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, et al. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99: 17020-17024 Epub 2002 Dec 05.
25. Chassin C, Vimont S, Cluzeaud F, Bens M, Goujon JM, et al. (2008) TLR4 facilitates translocation of bacteria across renal collecting duct cells. J Am Soc Nephrol 19: 2364-2374.
26. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E, (2012) Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 80: 1554-1562.
27. Chassin C, Goujon JM, Darche S, du Merle L, Bens M, et al. (2006) Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and-independent inflammatory pathways. J Immunol 177: 4773-4784.
28. Hung CS, Dodson KW, Hultgren SJ, (2009) A murine model of urinary tract infection. Nat Protoc 4: 1230-1243.
29. Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT, (1998) Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun 66: 2798-2802.
30. Schilling JD, Lorenz RG, Hultgren SJ, (2002) Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70: 7042-7049.
31. Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ, (2010) Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6: e1001042.
32. Song J, Abraham SN, (2008) Innate and adaptive immune responses in the urinary tract. Eur J Clin Invest 38 Suppl 2: 21-28.
33. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, et al. (2007) Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 24: 2373-2384.
34. Lane MC, Alteri CJ, Smith SN, Mobley HL, (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 104: 16669-16674.
35. Chassin C, Hornef MW, Bens M, Lotz M, Goujon JM, et al. (2007) Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J Exp Med 204: 2837-2852.
36. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, et al. (2011) Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6: e26578.
37. Hang L, Haraoka M, Agace WW, Leffler H, Burdick M, et al. (1999) Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J Immunol 162: 3037-3044.
38. Frendeus B, Godaly G, Hang L, Karpman D, Lundstedt AC, et al. (2000) Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192: 881-890.
39. Lane MC, Mobley HL, (2007) Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 72: 19-25.
40. Schilling JD, Martin SM, Hung CS, Lorenz RG, Hultgren SJ, (2003) Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 100: 4203-4208.
41. Song J, Duncan MJ, Li G, Chan C, Grady R, et al. (2007) A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog 3: e60.
42. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, et al. (1984) Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46: 839-844.
43. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, et al. (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64: 274-277.
44. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, et al. (2008) Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 46: 3900-3905.
45. Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, et al. (2012) Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 18: 598-607.
46. Pitout JD, Gregson DB, Campbell L, Laupland KB, (2009) Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53: 2846-2851.
47. Clermont O, Olier M, Hoede C, Diancourt L, Brisse S, et al. (2011) Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect Genet Evol 11: 654-662.
48. Ejrnaes K, Stegger M, Reisner A, Ferry S, Monsen T, et al. (2011) Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence 2: 528-537.
49. Ghigo JM, (2001) Natural conjugative plasmids induce bacterial biofilm development. Nature 412: 442-445.
50. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, et al. (2012) Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 56: 2364-2370.
51. Coelho A, Mora A, Mamani R, Lopez C, Gonzalez-Lopez JJ, et al. (2011) Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 66: 517-526.
52. Lescat M, Clermont O, Woerther PL, Glodt J, Dion S, et al. (2012) Commensal Escherichia coli strains in Guiana reveal a high genetic diversity with host-dependant population structure. Submitted.
53. Clermont O, Bonacorsi S, Bingen E, (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-4558.
54. Jaureguy F, Landraud L, Passet V, Diancourt L, Frapy E, et al. (2008) Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 9: 560.
55. Wirth T, Falush D, Lan R, Colles F, Mensa P, et al. (2006) Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60: 1136-1151.
56. Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, et al. (2011) Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49: 777-783.